Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
about
Mesenchymal Stem Cells after Polytrauma: Actor and TargetHoming and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?The effect of adipose tissue-derived stem cells in a middle cerebral artery occlusion stroke model depends on their engraftment rateComparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells.Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy.Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit.Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?Origin-Specific Adhesive Interactions of Mesenchymal Stem Cells with Platelets Influence Their Behavior After Infusion.Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells.Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase.Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine.Icariin Promotes the Migration of BMSCs In Vitro and In Vivo via the MAPK Signaling PathwayIntravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in RatClinical Cellular Therapeutics Accelerate Clot Formation
P2860
Q26747314-BAF62894-88E0-4010-A469-3F496CE344D7Q26750318-84F6FD74-129B-40F4-A944-97E09C42D824Q33608949-5E086C72-081C-4DC5-A682-EC1DC5CCA9C7Q37369187-5D6EC6FB-1707-44B4-BA73-07E9731162DFQ37541843-C996E0D7-EBA5-42F5-B2FA-3BD66201FCC4Q38733373-F91BF8DA-80D4-4F81-A791-50302BA58AFFQ47155255-AF1CF6B3-9701-405E-AB70-5A0996B8E655Q50224283-92EB4ECE-F517-4533-B56B-0FEDE72A3D25Q51746650-993B30EE-0E9E-456A-B6EC-3C477F4AE58BQ52673002-925F70DF-490D-4408-818D-D3BAB7C346F4Q55401793-4799B00C-BC41-4B98-A966-051515EA480AQ55508260-EC15C045-FA7B-41BF-AAB8-F678D932FD0FQ55554052-42405902-7702-45D1-9E67-D388BBCAFFC9Q57493183-7FFD919E-1DA5-40CE-BC7E-01A8A8F7486FQ58750327-DA561B3C-BE98-4723-BCAC-302D6EBE4615Q58804089-56899EF0-62E8-478D-94F7-1310BF8EA2BD
P2860
Bone Marrow-Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Bone Marrow-Derived Mesenchyma ...... ation by Antithrombin Therapy.
@en
Bone Marrow-Derived Mesenchyma ...... ation by Antithrombin Therapy.
@nl
type
label
Bone Marrow-Derived Mesenchyma ...... ation by Antithrombin Therapy.
@en
Bone Marrow-Derived Mesenchyma ...... ation by Antithrombin Therapy.
@nl
prefLabel
Bone Marrow-Derived Mesenchyma ...... ation by Antithrombin Therapy.
@en
Bone Marrow-Derived Mesenchyma ...... ation by Antithrombin Therapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Bone Marrow-Derived Mesenchyma ...... ration by Antithrombin Therapy
@en
P2093
Alessia Stocca
Arun H S Kumar
Birgitta M Gleeson
Derek Whelan
Kenneth Martin
M Gopala-Krishnan Pillai
Mohammed T Ali
Sujith P G Kumar
Wisam Khider
P2860
P304
P356
10.1002/STEM.2050
P577
2015-06-04T00:00:00Z